Wordt geladen...
Lorazepam Dose-dependently Decreases Risk-taking Related Activation in Limbic Areas
RATIONALE: Several studies have examined the role of different neurotransmitter systems in modulating risk-taking behavior. OBJECTIVE: This investigation was aimed to determine whether the benzodiazepine lorazepam dose-dependently alters risk-taking behavior and underlying neural substrates. METHODS...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2006
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2839080/ https://ncbi.nlm.nih.gov/pubmed/17016713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-006-0519-8 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|